These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14748845)

  • 1. Serum concentrations of insulin-like growth factor-1, soluble tumor necrosis factor receptor-1 and angiogenin in endometriosis patients.
    Steff AM; Gagné D; Pagé M; Rioux A; Hugo P; Gosselin D
    Am J Reprod Immunol; 2004 Feb; 51(2):166-73. PubMed ID: 14748845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble tumor necrosis factor-alpha receptors in the serum of endometriosis patients.
    Othman ER; Hornung D; Hussein M; Abdelaal II; Sayed AA; Fetih AN; Al-Hendy A
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():1-5. PubMed ID: 26963895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis.
    Gonzalez-Calvin JL; Gallego-Rojo F; Fernandez-Perez R; Casado-Caballero F; Ruiz-Escolano E; Olivares EG
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4325-30. PubMed ID: 15356028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concentration of selected angiogenic factors in serum and peritoneal fluid of women with endometriosis].
    Gogacz M; Gałczyński K; Romanek-Piva K; Winkler I; Rechberger T; Adamiak-Godlewska A
    Ginekol Pol; 2015 Mar; 86(3):188-92. PubMed ID: 25920308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased concentrations of soluble tumour necrosis factor receptor (sTNFR) I and II in peritoneal fluid from women with endometriosis.
    Koga K; Osuga Y; Tsutsumi O; Okagaki R; Momoeda M; Yano T; Fujiwara T; Takai Y; Kugu K; Morita Y; Taketani Y
    Mol Hum Reprod; 2000 Oct; 6(10):929-33. PubMed ID: 11006322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration of soluble intercellular adhesion molecule-1 in serum samples from patients with endometriosis collected during the luteal phase of the menstrual cycle.
    Steff AM; Gagné D; Pagé M; Hugo P; Gosselin D
    Hum Reprod; 2004 Jan; 19(1):172-8. PubMed ID: 14688178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function.
    Díez JJ; Hernanz A; Medina S; Bayón C; Iglesias P
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):515-21. PubMed ID: 12354134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor (TNF)-TNF receptor gene polymorphisms and their serum levels in Korean women with endometriosis.
    Chae SJ; Kim H; Jee BC; Suh CS; Kim SH; Kim JG
    Am J Reprod Immunol; 2008 Nov; 60(5):432-9. PubMed ID: 19238748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-alpha and TNF soluble receptors in women with overweight and obesity.
    Olszanecka-Glinianowicz M; Zahorska-Markiewicz B; Janowska J; Zurakowski A
    Metabolism; 2004 Oct; 53(10):1268-73. PubMed ID: 15375781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of soluble tumor necrosis factor receptors and tumor necrosis factor-alpha by alveolar macrophages in sarcoidosis and extrinsic allergic alveolitis.
    Dai H; Guzman J; Chen B; Costabel U
    Chest; 2005 Jan; 127(1):251-6. PubMed ID: 15653992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-Reactive protein and insulin growth factor 1 serum levels during the menstrual cycle in adolescents with Type 1 diabetes.
    Codner E; Merino PM; Martínez D; Lopez P; Godoy C; Iñiguez G; Cassorla F; Perez-Bravo F
    Diabet Med; 2016 Jan; 33(1):70-6. PubMed ID: 26043285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of soluble tumor necrosis factor-p55 levels in the serum and ascitic fluid of patients with hepatocellular carcinoma.
    Gao L; Bai L; Nan QZ; Yang XS; Chen K; Wen HP; Lai ZS; Bo L; Zhang YL; Zhang ZS
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):641-3. PubMed ID: 12376300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologic oncology group study.
    Burger RA; Darcy KM; DiSaia PJ; Monk BJ; Grosen EA; Gatanaga T; Granger GA; Wang J; Tian C; Hanjani P; Cohn DE
    Cancer; 2004 Jul; 101(1):106-15. PubMed ID: 15221995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum levels of solubule tumor necrosis factor (TNF) receptors in patients with pulmonary tuberculosis].
    Kawaguchi H; Ina Y; Ito S; Sato S; Sugiura Y; Tomita H; Ogisu N; Takada K; Yamamoto M; Morishita M; Yoshikawa K
    Kekkaku; 1996 Mar; 71(3):259-65. PubMed ID: 8901228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monocyte tumor necrosis factor and tumor necrosis factor receptor expression in patients with alcoholic liver cirrhosis].
    He S; Huang H
    Zhonghua Nei Ke Za Zhi; 1997 Aug; 36(8):526-8. PubMed ID: 10436957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased serum angiogenin level in Alzheimer's disease.
    Kim YN; Kim DH
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):116-20. PubMed ID: 22449478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of alpha-fetoprotein, insulin-like growth factor binding protein-3, c-erbB-2, and epidermal growth factor in serum of patients with endometriosis.
    Philippoussis F; Gagné D; Hugo P; Gosselin D
    J Soc Gynecol Investig; 2004 Apr; 11(3):175-81. PubMed ID: 15051037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and significance of serum soluble tumor necrosis factor receptor-I in patients with head and neck neoplasm].
    Dong W; Xu J; Qiao Z; Wang N; Yu R
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):468-70. PubMed ID: 12761967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus.
    Aderka D; Wysenbeek A; Engelmann H; Cope AP; Brennan F; Molad Y; Hornik V; Levo Y; Maini RN; Feldmann M
    Arthritis Rheum; 1993 Aug; 36(8):1111-20. PubMed ID: 8393677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.